Page results
-
The flow cytometry laboratory provides a Haematological Malignancy diagnostic service which includes chronic and acute leukaemias and lymphomas.
-
Her Majesty The Queen’s state funeral will be held on Monday 19 September, and will be a national bank holiday.
-
Alternatives to Accident and Emergency (A&E) and attending the Emergency Department (Casualty) at UCLH
-
Between April 2021 and March 2022, 40% of UCLH outpatient appointments took place virtually - a total of 484,872 appointments – the highest in England.
-
This page provides general information about the procedure called anterior cervical discectomy.
-
The cochlear implant programme was founded in 1982, and we were the first clinical cochlear implant programme in the UK. The team has been involved with the successful implantation of more than 2,000 patients, both adults and children, from all over the UK.
-
This booklet has been written by the Autonomic Unit at The National Hospital for Neurology and Neurosurgery (NHNN). The aim of the booklet is to provide information about the autonomic function test (AFT).
-
This page explains how our plasma cell multidisciplinary team (MDT) will support you during treatmen
-
Dr Richard Sylvester is a consultant neurologist with an interest in traumatic brain injuries.
-
UCLH cancer services are closely located in and around University College Hospital, which is a one-minute walk from Warren Street and Euston Square tube stations. It’s a 15-minute walk from London King’s Cross St Pancras and Euston stations, and a few minutes on the Circle Line from Paddington Station.
File results
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer